Data / Form D filings / ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc.: Form D filings
ENDRA Life Sciences Inc., a biotechnology company in Ann Arbor, MI, filed 4 Form D notices with the SEC between 2018 and 2025. The latest, on October 24, 2025, reports $14.4 million sold of a $14.4 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3600 GREEN COURT, SUITE 350, Ann Arbor, MI, 48105
- Phone
- (734) 335-0468
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1681682
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | New notice | $14,402,880 | $14,402,880 | 6 | Oct 10, 2025 | sec.gov | |
| Dec 20, 2019 | New notice | $8,555,000 | $8,555,000 | 151 | Dec 5, 2019 | sec.gov | |
| Jul 31, 2019 | New notice | $2,805,000 | $2,805,000 | 86 | Jul 26, 2019 | sec.gov | |
| Jul 3, 2018 | New notice | $1,097,000 | $1,077,000 | $20,000 | 18 | Jun 21, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Thornton | Executive Officer | |
| Richard Jacroux | Executive Officer | |
| Louis J. Basenese | Director | |
| Anthony J. DiGiandomenico | Director | |
| Michael J. Harsh | Director | |
| Alexander Tokman | Executive Officer, Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ENDRA Life Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.